|
Sign In to gain access to subscriptions and/or personal tools.
|
Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia
Joyce A. Deleo
Department of Anesthesiology and Department of Pharmacology & Toxicology, DartmouthHitchcock Medical Center, Lebanon, NH.Joyce.A.DeLeo{at}Dartmouth.edu
Flobert Y. Tanga
Vivianne L. Tawfik
Department of Anesthesiology and Department of Pharmacology & Toxicology, DartmouthHitchcock Medical Center, Lebanon, NH.
One area that has emerged as a promising therapeutic target for the treatment and prevention of chronic pain and opioid tolerance/hyperalgesia is the modulation of the central nervous system (CNS) immunological response that ensues following injury or opioid administration. Broadly defined, central neuroimmune activation involves the activation of cells that interface with the peripheral nervous system and blood. Activation of these cells, as well as parenchymal microglia and astrocytes by injury, opioids, and other stressors, leads to subsequent production of cytokines, cellular adhesion molecules, chemokines, and the expression of surface antigens that enhance a CNS immune cascade. This response can lead to the production of numerous pain mediators that can sensitize and lower the threshold of neuronal firing: the pathologic correlate to central sensitization and chronic pain states. CNS innate immunity and Toll-like receptors, in particular, may be vital players in this orchestrated immune response and may hold the answers to what initiates this complex cascade. The challenge remains in the careful perturbation of injury/opioid-induced neuroimmune activation to down-regulate this process without inhibiting beneficial CNS autoimmunity that subserves neuronal protection following injury.
Key Words: Astrocyte Chemokines Cytokines Glia MHC II Microglia Neuropathic pain Toll-like receptor 4
The Neuroscientist, Vol. 10, No. 1,
40-52 (2004)
DOI: 10.1177/1073858403259950

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Costigan, A. Moss, A. Latremoliere, C. Johnston, M. Verma-Gandhu, T. A. Herbert, L. Barrett, G. J. Brenner, D. Vardeh, C. J. Woolf, et al.
T-Cell Infiltration and Signaling in the Adult Dorsal Spinal Cord Is a Major Contributor to Neuropathic Pain-Like Hypersensitivity
J. Neurosci.,
November 18, 2009;
29(46):
14415 - 14422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. White, P. Feldman, and R. J. Miller
Chemokine Signaling and the Management of Neuropathic Pain
Mol. Interv.,
August 1, 2009;
9(4):
188 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dou, C. B. Grotepas, J. M. McMillan, C. J. Destache, M. Chaubal, J. Werling, J. Kipp, B. Rabinow, and H. E. Gendelman
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS
J. Immunol.,
July 1, 2009;
183(1):
661 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wei, W. Guo, S. Zou, K. Ren, and R. Dubner
Supraspinal Glial-Neuronal Interactions Contribute to Descending Pain Facilitation
J. Neurosci.,
October 15, 2008;
28(42):
10482 - 10495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Griffin, M. Costigan, G. J. Brenner, C. Him Eddie Ma, J. Scholz, A. Moss, A. J. Allchorne, G. L. Stahl, and C. J. Woolf
Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity
J. Neurosci.,
August 8, 2007;
27(32):
8699 - 8708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Xu, B. C. Walla, M. F. Diaz, G. N. Fuller, and H. B. Gutstein
Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance.
Anesth. Analg.,
September 1, 2006;
103(3):
714 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Y. Tanga, N. Nutile-McMenemy, and J. A. DeLeo
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
PNAS,
April 19, 2005;
102(16):
5856 - 5861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal.,
September 28, 2004;
2004(252):
re14 - re14.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|